「Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase」の関連論文
-
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
-
Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
Dissecting the Intracellular Molecular Mechanisms to Address Pathogenesis of Multifactorial Diseases
-
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (本文)
-
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation
-
Differential effects of sevoflurane on the growth and apoptosis of human cancer cell lines
-
Establishment and analysis of a mouse model conditionally expressing the Helicobacter pylori CagA oncoprotein
-
Glycoprotein NMB functions with growth factor signaling to induce tumorigenesis in breast cancer cells
-
A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues
-
The role of vagus nerve stimulation through acetylcholine receptor during atherosclerosis progression
-
TSC22D4/THG-1 suppresses cellular senescence in esophageal squamous cell carcinoma
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
MicroRNA-124a Inhibits Endoderm Lineage Commitment in Mouse Embryonic Stem Cells
-
Study on the biological significance of YAP gene alternative splicing
-
Involvement of Transcription Factor 21 in the Pathogenesis of Fibrosis in Endometriosis
-
Escin inhibits angiogenesis by suppressing interleukin-8 and vascular endothelial growth factor production by blocking nuclear factor-κB activation in pancreatic cancer cell lines
-
Identification and characterization of slow‑cycling cells in Ewing sarcoma
-
SEPSIS INDUCES DEREGULATION OF IL-13 PRODUCTION AND PD-1 EXPRESSION IN LUNG GROUP 2 INNATE LYMPHOID CELLS
-
Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature
-
Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease
-
Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma
-
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Genome-scale CRISPR/Cas9 screening for gemcitabine modulators in pancreatic cancer
-
Serum amyloid alpha 1-2 are not required for liver inflammation in the 4T1 murine breast cancer model
-
Study on the role of CtBP2 in pancreatic β cell
-
Elucidation of HHEX in pancreatic endoderm differentiation using a human iPSC differentiation model
-
Functional Analysis of Cancer-associated IDH mutations
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Targeting tumor-intrinsic Nuclear Factor-kappa B signaling pathway for the discovery of anti-metastatic drug candidates from natural recourses
-
Analysis of the molecular mechanisms that activate cell proliferation in Xenopus tropicalis tadpole tail regeneration
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Myogenetic Oligodeoxynucleotide Restores Differentiation and Reverses Inflammation of Myoblasts Aggravated by Cancer-Conditioned Medium
-
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
-
Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells
-
Nectin-4 regulates cellular senescence-associated enlargement of cell size
-
Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
-
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
-
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function